Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC

Urothelial carcinoma (UC) is a common malignancy of the lower and upper urinary tract. Recurrent UC has poor prognosis due to delayed diagnosis and a lack of clinical management guidance, especially for upper urinary tract UC. Patients with germline or somatic BRCA1/2 mutations are a special populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Liu, Zhimin, Wang, Yufang, Li, Jun, Li, Ruiqian, Wang, Qilin, Hu, Chen, Jiang, Haiyang, Wu, Hongyi, Song, Lele, Bai, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675892/
https://www.ncbi.nlm.nih.gov/pubmed/33240400
http://dx.doi.org/10.1177/1758835920970845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675892/
https://www.ncbi.nlm.nih.gov/pubmed/33240400
http://dx.doi.org/10.1177/1758835920970845

Ejemplares similares